iCoreConnect Inc. (ICCT)
USD 2.34
(-17.61%)
USD 2.34
(-17.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.24 Million USD | 24.12% |
| 2022 | 9.05 Million USD | 61.02% |
| 2021 | 5.62 Million USD | 69.45% |
| 2020 | 3.31 Million USD | 61.38% |
| 2019 | 2.05 Million USD | -23.62% |
| 2018 | 2.69 Million USD | -8.53% |
| 2017 | 2.94 Million USD | 0.0% |
| 2015 | 13.62 Million USD | 20.12% |
| 2014 | 11.34 Million USD | -14.77% |
| 2013 | 13.31 Million USD | 63.65% |
| 2012 | 8.13 Million USD | 54.08% |
| 2011 | 5.27 Million USD | -39.11% |
| 2010 | 8.66 Million USD | 29.63% |
| 2009 | 6.68 Million USD | 35.29% |
| 2008 | 4.94 Million USD | 55.88% |
| 2007 | 3.17 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 17.02 Million USD | 18.55% |
| 2024 Q1 | 14.35 Million USD | 27.71% |
| 2023 Q4 | 11.24 Million USD | 12.42% |
| 2023 Q2 | 10.63 Million USD | 10.55% |
| 2023 Q1 | 9.61 Million USD | 6.2% |
| 2023 Q3 | 10 Million USD | -5.96% |
| 2023 FY | 11.24 Million USD | 24.12% |
| 2022 Q3 | 8.66 Million USD | 8.03% |
| 2022 Q1 | 7.81 Million USD | 38.93% |
| 2022 FY | 9.05 Million USD | 61.02% |
| 2022 Q2 | 8.01 Million USD | 2.6% |
| 2022 Q4 | 9.05 Million USD | 4.57% |
| 2021 Q3 | 5.31 Million USD | 58.2% |
| 2021 Q4 | 5.62 Million USD | 5.86% |
| 2021 FY | 5.62 Million USD | 69.45% |
| 2021 Q1 | 2.17 Million USD | -34.45% |
| 2021 Q2 | 3.35 Million USD | 54.35% |
| 2020 FY | 3.31 Million USD | 61.38% |
| 2020 Q3 | 2.6 Million USD | 9.53% |
| 2020 Q4 | 3.31 Million USD | 27.24% |
| 2020 Q1 | 2.16 Million USD | 5.1% |
| 2020 Q2 | 2.38 Million USD | 10.18% |
| 2019 Q3 | 1.99 Million USD | -28.79% |
| 2019 Q4 | 2.05 Million USD | 2.9% |
| 2019 FY | 2.05 Million USD | -23.62% |
| 2019 Q2 | 2.8 Million USD | 3.12% |
| 2019 Q1 | 2.72 Million USD | 1.08% |
| 2018 FY | 2.69 Million USD | -8.53% |
| 2018 Q4 | 2.69 Million USD | -8.4% |
| 2018 Q3 | 2.94 Million USD | -7.75% |
| 2018 Q2 | 3.18 Million USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q4 | 2.94 Million USD | 0.0% |
| 2017 FY | 2.94 Million USD | 0.0% |
| 2015 FY | 13.62 Million USD | 20.12% |
| 2015 Q1 | 10.34 Million USD | -8.88% |
| 2014 Q1 | 7.28 Million USD | 4.99% |
| 2014 FY | 11.34 Million USD | -14.77% |
| 2014 Q4 | 11.35 Million USD | -6.26% |
| 2014 Q3 | 12.11 Million USD | 6.77% |
| 2014 Q2 | 11.34 Million USD | 55.63% |
| 2013 Q1 | 8.43 Million USD | 5.28% |
| 2013 FY | 13.31 Million USD | 63.65% |
| 2013 Q4 | 6.94 Million USD | 2.15% |
| 2013 Q3 | 6.79 Million USD | -48.94% |
| 2013 Q2 | 13.31 Million USD | 57.73% |
| 2012 Q1 | 6.12 Million USD | 5.82% |
| 2012 FY | 8.13 Million USD | 54.08% |
| 2012 Q3 | 7.99 Million USD | -1.74% |
| 2012 Q4 | 8.01 Million USD | 0.3% |
| 2012 Q2 | 8.13 Million USD | 32.78% |
| 2011 Q3 | 5.5 Million USD | 4.22% |
| 2011 Q1 | 5.69 Million USD | 10.2% |
| 2011 Q2 | 5.27 Million USD | -7.26% |
| 2011 Q4 | 5.78 Million USD | 5.21% |
| 2011 FY | 5.27 Million USD | -39.11% |
| 2010 Q4 | 5.16 Million USD | -41.19% |
| 2010 FY | 8.66 Million USD | 29.63% |
| 2010 Q1 | 7.34 Million USD | -0.89% |
| 2010 Q2 | 8.66 Million USD | 18.11% |
| 2010 Q3 | 8.78 Million USD | 1.32% |
| 2009 FY | 6.68 Million USD | 35.29% |
| 2009 Q2 | 6.68 Million USD | 18.82% |
| 2009 Q4 | 7.4 Million USD | 4.79% |
| 2009 Q3 | 7.06 Million USD | 5.68% |
| 2009 Q1 | 5.62 Million USD | 21.17% |
| 2008 FY | 4.94 Million USD | 55.88% |
| 2008 Q4 | 4.64 Million USD | 10.21% |
| 2008 Q2 | 4.94 Million USD | -7.09% |
| 2008 Q3 | 4.21 Million USD | -14.73% |
| 2008 Q1 | 5.32 Million USD | 4.74% |
| 2007 Q2 | 3.17 Million USD | 0.0% |
| 2007 FY | 3.17 Million USD | 0.0% |
| 2007 Q4 | 5.07 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accolade, Inc. | 342.68 Million USD | 96.719% |
| Aclarion, Inc. | 3.18 Million USD | -252.671% |
| Aclarion, Inc. | 3.18 Million USD | -252.671% |
| Augmedix, Inc. | 43.39 Million USD | 74.091% |
| HeartBeam, Inc. | 1.19 Million USD | -841.569% |
| HeartBeam, Inc. | 1.19 Million USD | -841.569% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -5998.365% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -5998.365% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.783% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.783% |
| CareCloud, Inc. | 37.79 Million USD | 70.256% |
| CareCloud, Inc. | 37.79 Million USD | 70.256% |
| CareCloud, Inc. | 37.79 Million USD | 70.256% |
| Certara, Inc. | 516.29 Million USD | 97.823% |
| CareMax, Inc. | 561.85 Million USD | 97.999% |
| CareMax, Inc. | 561.85 Million USD | 97.999% |
| Definitive Healthcare Corp. | 626.72 Million USD | 98.206% |
| EUDA Health Holdings Limited | 8.79 Million USD | -27.864% |
| EUDA Health Holdings Limited | 8.79 Million USD | -27.864% |
| Forian Inc. | 33.19 Million USD | 66.134% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 98.64% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.955% |
| Health Catalyst, Inc. | 334.89 Million USD | 96.643% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -18.204% |
| HealthEquity, Inc. | 1.2 Billion USD | 99.064% |
| HealthStream, Inc. | 159.19 Million USD | 92.938% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 99.11% |
| MSP Recovery, Inc. | 1.74 Billion USD | 99.354% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -3972.735% |
| National Research Corporation | 73.48 Million USD | 84.701% |
| Nutex Health, Inc. | 319.13 Million USD | 96.477% |
| Omnicell, Inc. | 1.03 Billion USD | 98.917% |
| OneMedNet Corporation | 13.32 Million USD | 15.615% |
| OptimizeRx Corporation | 56.82 Million USD | 80.214% |
| Ontrak, Inc. | 5.57 Million USD | -101.656% |
| Ontrak, Inc. | 5.57 Million USD | -101.656% |
| Progyny, Inc. | 203.19 Million USD | 94.467% |
| Premier, Inc. | 1.46 Billion USD | 99.233% |
| Privia Health Group, Inc. | 392.51 Million USD | 97.136% |
| R1 RCM Inc. | 2.2 Billion USD | 99.491% |
| Renalytix Plc | 15.82 Million USD | 28.963% |
| Schrödinger, Inc. | 254.39 Million USD | 95.581% |
| Sharecare, Inc. | 125.56 Million USD | 91.047% |
| Sharecare, Inc. | 125.56 Million USD | 91.047% |
| SHL Telemedicine Ltd. | 36.58 Million USD | 69.273% |
| Simulations Plus, Inc. | 14.2 Million USD | 20.873% |
| SOPHiA GENETICS SA | 54.71 Million USD | 79.453% |
| Spok Holdings, Inc. | 63.91 Million USD | 82.41% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | 50.963% |
| TruBridge, Inc. | 247.8 Million USD | 95.463% |
| 10x Genomics, Inc. | 224.1 Million USD | 94.983% |
| Minerva Surgical, Inc. | 51.71 Million USD | 78.263% |
| GeneDx Holdings Corp. | 245.65 Million USD | 95.424% |
| GeneDx Holdings Corp. | 245.65 Million USD | 95.424% |
| SCWorx Corp. | 2.42 Million USD | -363.646% |
| Zhongchao Inc. | 3.37 Million USD | -232.764% |